DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,363,082 | +19.6% | 9,524 | +15.6% | 0.04% | +19.4% |
| Q2 2023 | $1,976,635 | +22.0% | 8,236 | +28.1% | 0.04% | 0.0% |
| Q1 2023 | $1,620,042 | -3.6% | 6,428 | +1.6% | 0.04% | -14.3% |
| Q4 2022 | $1,679,711 | +13.8% | 6,328 | +10.8% | 0.04% | 0.0% |
| Q3 2022 | $1,476,000 | +0.1% | 5,712 | -1.8% | 0.04% | 0.0% |
| Q2 2022 | $1,475,000 | -1.0% | 5,819 | +14.5% | 0.04% | +10.5% |
| Q1 2022 | $1,490,000 | -23.0% | 5,080 | -13.6% | 0.04% | -22.4% |
| Q4 2021 | $1,934,000 | +27.0% | 5,877 | +17.4% | 0.05% | +11.4% |
| Q3 2021 | $1,523,000 | +46.2% | 5,004 | +33.8% | 0.04% | +29.4% |
| Q2 2021 | $1,042,000 | +25.7% | 3,740 | +1.5% | 0.03% | +6.2% |
| Q1 2021 | $829,000 | +172.7% | 3,686 | +169.2% | 0.03% | +128.6% |
| Q4 2020 | $304,000 | -26.4% | 1,369 | -39.5% | 0.01% | -50.0% |
| Q2 2020 | $413,000 | +1620.8% | 2,261 | +1322.0% | 0.03% | +1300.0% |
| Q4 2019 | $24,000 | -90.6% | 159 | -91.6% | 0.00% | -90.5% |
| Q3 2019 | $255,000 | -17.5% | 1,894 | -14.8% | 0.02% | -27.6% |
| Q2 2019 | $309,000 | – | 2,223 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |